Anti‐spasticity agents for multiple sclerosis
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Anti‐spasticity Agents for Multiple Sclerosis." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/432085/all/Anti‐spasticity_agents_for_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed 28 March 2024.
Anti‐spasticity agents for multiple sclerosis. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/all/Anti‐spasticity_agents_for_multiple_sclerosis_Edited__no_change_to_conclusions_. Accessed March 28, 2024.
Anti‐spasticity agents for multiple sclerosis. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/all/Anti‐spasticity_agents_for_multiple_sclerosis_Edited__no_change_to_conclusions_
Anti‐spasticity Agents for Multiple Sclerosis [Internet]. In: Cochrane Abstracts. [cited 2024 March 28]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/all/Anti‐spasticity_agents_for_multiple_sclerosis_Edited__no_change_to_conclusions_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Anti‐spasticity agents for multiple sclerosis
ID - 432085
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/432085/all/Anti‐spasticity_agents_for_multiple_sclerosis_Edited__no_change_to_conclusions_
DB - Evidence Central
DP - Unbound Medicine
ER -